[ET Net News Agency, 9 October 2025] REMEGEN (09995) fell 9.9% to HK$107.8.
It hits an intra-day low of HK$107.4, dipping below the 20-D SMA of HK$110.42, and an
intra-day high of HK$118. The total shares traded was 4.86 million, with a value of
HK$541.89m. The active buy/sell ratio is 32:68, with net selling turnover of HK$180.53m.
CHINA INV INFO accounts for greatest net responsive buying turnover of HK$49.83m, with
volume weighted average price of HK$111.462. BARCLAYS CAPITAL ASIA accounts for greatest
net responsive selling turnover of HK$11.95m, with volume weighted average price of
HK$110.217. The stock has fallen a combined 13.8% over the past 3 consecutive trading
days.

Basic Information
=================

-----------------------------------
Nominal 107.800 % Chg -9.87%
High 118.000 Low 107.400
Shares Tr 4.86m Turnover 541.89m
10-D SMA 113.970 %H.V 68.068
20-D SMA 110.420 VWAP 111.483
50-D SMA 91.867 RSI14 51.639
-----------------------------------
Status: Dipping below the 20-D SMA, active buy/sell ratio is 32:68, with net selling
turnover of HK$180.53m, falling a combined 13.8% over the past 3 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
----------------------------------------------
REMEGEN (09995) 107.80 -9.87
SINO BIOPHARM (01177) 7.97 -6.67
HENGRUI PHARMA (01276) 88.05 -3.24
3SBIO (01530) 29.10 -5.95
EVEREST MED (01952) 56.45 -0.96
WUXI XDC (02268) 77.90 -5.92
SKB BIO-B (06990) 528.00 -8.57
DUALITYBIO-B (09606) 325.80 +0.87
AKESO (09926) 134.20 -5.36
INNOCARE (09969) 16.34 -13.13
----------------------------------------------
(ed)